Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAscent Resources Regulatory News (AST)

Share Price Information for Ascent Resources (AST)

Share Price is delayed by 15 minutes
Get Live Data
0.475    0.075 (18.75%)
Bid:
0.45
Ask:
0.50
Spread: 0.05 (11.111%)
Market Cap: £3.95m
AST Live PriceLast checked at - London Stock Exchange

Intraday Ascent Resources Share Chart

Directors' conversion of loan notes

30 May 2017 08:43

RNS Number : 5226G
Ascent Resources PLC
30 May 2017
 

30 May 2017

Ascent Resources plc

 

("Ascent" or the "Company")

 

Conversion of Loan Notes held by the board

 

Ascent Resources plc, the AIM quoted European oil and gas exploration and production company has, following a request from the Company, received notices of exercise ("the Notices") to convert 67,500 convertible loan notes of £1 each held by members of the Ascent board:

 

- 17,500 of which were issued in May 2013 as part of an open offer to all shareholders (the "2013 Loan Notes") and the terms of which were amended in February 2015 and October 2016.

- 50,000 of which were issued to the Directors pursuant to the fundraising announced on 27 October 2016 ("2016 Loan Notes").

 

Each of the 2013 Loan Notes, including rolled up interest, and the 2016 Loan Notes are convertible into new Ordinary Shares at a rate of 100 new Ordinary Shares per £1 loan note. Consequently, a total of 6,970,931 new Ordinary Shares ("the Conversion Shares") will be issued pursuant to the Notices.

 

This has been done to assist the Company in further removing debt. None of the Directors currently intend to sell any of their shareholdings.

 

The decision to convert the Loan Notes reflects in part that since January 2015 the outstanding Loan Notes have carried no interest payments and have only preferential rights compared to the Ordinary Shares in limited circumstances, such as a winding up of the Company.

 

Following the Directors' loan note conversions, which comprise 100% of the loan notes held by the board, £3,191,489 nominal convertible loan notes (including rolled-up interest) remain outstanding. The 2016 Loan Notes have now been fully converted.

 

The table below details the Directors' interests.

 

Director

Loan Notes converted

New Ordinary Shares received

Resultant shareholding

%

Clive Carver

30,883

3,304,231

3,304,231

0.18%

Colin Hutchinson

10,001

1,000,100

1,270,370

0.07%

Nigel Moore

13,333

1,333,300

1,339,275

0.07%

Cameron Davies

13,333

1,333,300

1,340,800

0.07%

 

Admission and Settlement

 

Application has been made for the admission to trading on AIM of the Conversion Shares ("Admission"). Admission is expected to occur on 5 June 2017. Following Admission, Ascent will have 1,835,618,526 Ordinary Shares in issue. There are no shares held in treasury. The total voting rights in the Company is therefore 1,835,618,526 and Shareholders may use this figure as the denominator by which they are required to notify their interest in, or change to their interest in, the Company under the Disclosure Guidance and Transparency Rules.

 

Clive Carver, Chairman commented

 

"It is pleasing that the entire board has agreed to convert their Loan Notes. This underlines the progress the Company has made in its financial standing."

 

Enquiries:

 

Ascent Resources plc 0207 251 4905

Clive Carver, Chairman

Colin Hutchinson, CEO

 

Stockdale Securities Limited, Nominated Adviser and Joint Broker 0207 601 6100

Richard Johnson

Edward Thomas

Northland Capital Partners Limited, Joint Broker 0203 861 6625

Tom Price

 

IFC Advisory Ltd, Financial PR and IR 0203 053 8671

Graham Herring

Tim Metcalfe

Heather Armstrong

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IODDBLBXDEFZBBB
Date   Source Headline
29th Oct 20243:53 pmRNSHolding(s) in Company
23rd Oct 20241:25 pmRNSHolding(s) in Company
9th Oct 20244:34 pmRNSBlock listing Interim Review
2nd Oct 20244:16 pmRNSHolding(s) in Company
19th Sep 20247:00 amRNSInterim results for the period ended 30 June 2024
18th Sep 20247:00 amRNSNew Premium Funding & TVR
30th Jul 20245:09 pmRNSHolding(s) in Company
15th Jul 20247:00 amRNSChange of Adviser
10th Jul 20245:19 pmRNSHolding(s) in Company
10th Jul 20245:16 pmRNSHolding(s) in Company
26th Jun 20241:51 pmRNSResult of AGM
24th Jun 20247:59 amRNSDirector Appointment
5th Jun 20244:31 pmRNSHolding(s) in Company
5th Jun 20244:29 pmRNSHolding(s) in Company
3rd Jun 20243:45 pmRNSBoard Changes & Appointment of CFO
31st May 20247:00 amRNSFinal Results
29th May 20249:27 amRNSNOTIFICATION OF MAJOR HOLDINGS
13th May 20247:00 amRNSDirectorate Change
10th May 20247:00 amRNSUpdate on US gas and helium investment
9th May 20244:49 pmRNSHolding(s) in Company
23rd Apr 20247:00 amRNSOnshore US Gas Investment, New Funding &TVR
18th Apr 20241:42 pmRNSGeoenergo Administration: RJOA Status & Claim
2nd Apr 20242:41 pmRNSConfirmation of Geoenergo d.o.o. administration
4th Mar 20243:25 pmRNSResults of General Meeting
28th Feb 202411:27 amRNSHolding(s) in Company
23rd Feb 20247:00 amRNSUpdate on ECT claim
5th Feb 20247:00 amRNSNotice of Record Date, GM & posting of Circular
1st Feb 202411:57 amRNSBlock listing Interim Review
19th Jan 20243:32 pmRNSUpdate on JV Partner’s Insolvency Proceedings
16th Jan 202410:34 amRNSHolding(s) in Company - Correction
15th Jan 20241:09 pmRNSHolding(s) in Company
15th Jan 20247:00 amRNSAscent Prevents JV Partner’s Immediate Insolvency
8th Jan 20243:13 pmRNSJV Partner Initiates Insolvency Proceedings
21st Dec 20237:00 amRNSUpgrade in Estimate of Revenue Recognition
1st Dec 20237:00 amRNSECT Claim Distribution Update
21st Nov 20231:30 pmRNSDirector Appointment
15th Nov 20235:41 pmRNSResult of GM
13th Nov 20232:40 pmRNSHolding(s) in Company
27th Oct 202312:22 pmRNSNotice of GM and ECT Claim Shareholder Discussion
26th Oct 20234:50 pmRNSHolding(s) in Company
25th Oct 202312:10 pmRNSSuccessful Revenue Recognition Arbitration
25th Oct 20237:00 amRNSDirectorate Change
19th Oct 20233:19 pmRNSHolding(s) in Company
17th Oct 202310:14 amRNSHolding(s) in Company
11th Oct 202310:35 amRNSCompletion of Strategic Investment & TVR
3rd Oct 20237:00 amRNSCornerstone investor & Collaboration Agreement
28th Sep 20237:00 amRNSInterim Results
22nd Sep 202312:07 pmRNSSlovenia ECT Claim: ATE insurance contracted
21st Sep 20233:35 pmRNSResult of General Meeting
18th Aug 20234:14 pmRNSNotice of General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.